Ardsley Advisory Partners’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,000
Closed -$138K 202
2017
Q1
$138K Buy
+10,000
New +$161K 0.02% 143

Other funds holding ENTL

Ardsley Advisory Partners's ENTL Position: Q2 2017 in Review

Ardsley Advisory Partners sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q2 2017, closing a stake of 10,000 shares — an estimated $138K sold.

Ardsley Advisory Partners first reported a position in ENTL in Q1 2017 and held it in 1 quarter. The position peaked at $138K in Q1 2017. 73 funds tracked by Wall St. Rank hold ENTL as of Q2 2017.

  • Ardsley Advisory Partners reported no remaining Entellus Medical, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Ardsley Advisory Partners sold 10,000 Entellus Medical, Inc. Common Stock shares in Q2 2017, an estimated $138K.
  • Ardsley Advisory Partners first reported a position in Entellus Medical, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • Ardsley Advisory Partners's Entellus Medical, Inc. Common Stock position peaked at $138K in Q1 2017.
  • 73 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q2 2017.

Based on Ardsley Advisory Partners's 13F filing for Q2 2017, filed 14 Aug 2017.